News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Nova Mentis to Present Promising Psilocybin Microdose Data at 18th NFXF International Fragile X Conference
Nova Mentis Life Science
Algernon Pharmaceuticals Provides Update on its Planned Phase 1 Repirinast Chronic Kidney Disease Study
Algernon Pharmaceuticals
Psychedelic Weekly Headlines | July 8th
Awakn Life Sciences
Nirvana Life Sciences
Filament Health
Algernon Pharmaceuticals
Lobe Sciences
Filament Health Announces First Dosing In Groundbreaking Fda-approved Psilocin Clinical Trial
Filament Health
Lobe Sciences Ltd. Announces Regulatory and Clinical Development Plans For 2022 and Early 2023
Lobe Sciences
Algernon Pharmaceuticals Provides Update on Its Phase 1 DMT Stroke Study
Algernon Pharmaceuticals
Clairvoyant Therapeutics Initiates First Site for Phase 2 Psilocybin Therapy Clinical Trial for Alcohol Use Disorder
Clairvoyant Therapeutics
Nirvana Life Sciences Inc. Announces License for a Delivery System for Psychedelic APIs
Nirvana Life Sciences
Filament Health Announces Sixth Patent Issuance
Filament Health
BetterLife Secures Additional Mitacs Funding in Collaboration with Carleton University Research Team for BETR-001 Preclinical Depression Studies
BetterLife Pharma
Cognetivity Neurosciences Enters Asia Via Pilot Agreement with Leading Singaporean Senior Care Network
Cognetivity Neurosciences
Algernon Pharmaceuticals Discloses Novel DMT Salt Patent Strategy Includes Bioactive Nicotinate and Pamoate
Algernon Pharmaceuticals
PharmAla Biotech appoints Kevin Roy to its Board of Directors
Pharmala Biotech Holdings
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.